Infertility study: ZyMōt Multi
Official title Microfluidic Chip Method Versus Density Gradient Centrifugation Method on Semen Parameters
ClinicalTrials.gov ID: NCT05978947
What this study is testing
- What it's testing
- The study aims to see if the chip method reduces DNA damage and improves sperm count and movement compared to the current method.
- Who it's for
- Men who are experiencing infertility and are attending a fertility clinic.
- What's involved
- Participants will provide a semen sample that will be processed by one of two methods. The processed samples will be tested for DNA fragmentation, sperm count, and motility. The results will not be used for treatment.
- Time commitment
- Participants will need to come in once to give a semen sample; no additional visits or long‑term commitment are required.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, men only. Healthy volunteers may be eligible.
You may be able to join if
- Sperm concentration of the raw semen with at least 5 million motile sperm per ml with a total volume of not less than 1.5ml.
You likely can't join if
- Sperm concentration of the raw semen of less than 5 million motile sperm per ml
- Men unable to provide an ejaculated semen sample
The study team makes the final eligibility decision.
Where it is enrolling
- Hong Kong, Hong Kong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, not specified. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Hong Kong, Hong Kong, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.